CTKB Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - Cytek Biosciences Inc

Watchlist Manager

Watchlist

Price: 5.68 USD -0.53% Market Closed

Market Cap: $733.5m

	Cytek Biosciences Inc NASDAQ:CTKB	US
S	Sino Land Co Ltd SWB:SNO	HK
	Nexa Resources SA NYSE:NEXA	LU
	Oculis Holding AG F:CR5	CH
C	Cigna Group XMUN:CGN	US
R	Randstad NV OTC:RANJF	NL
	Perpetual Ltd ASX:PPT	AU

Profitability Summary

Cytek Biosciences Inc's profitability score is Hidden . We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Exceptional Gross Margin

53%

Strong 3Y Average Gross Margin

55%

Declining Gross Margin

60% > 53%

Negative Operating Margin

-22%

Negative 3Y Average Operating Margin

-15%

Declining Operating Margin

-11% > -22%

Negative Net Margin

-39%

Negative 3Y Average Net Margin

-13%

Declining Net Margin

-3% > -39%

Negative Free Cash Flow Margin

-6%

Sustainable 3Y Average Free Cash Flow Margin

Free Cash Flow Margin is Increasing

-6% > -6%

Negative ROE

-23%

Negative 3Y Average ROE

Negative 3Y Average ROIC

-20%

Declining ROIC

-7% > -44%

View All Checks

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.